This symposium offers an exploration of the latest advancements in human stem cell research, focusing on developments in both Geneva and Lausanne. Supported by the NeuroNA Foundation, it will showcase the cutting-edge platforms in both cities, shedding light on the remarkable progress achieved in the field. The event will explore the promising potential of induced pluripotent stem cells and organoids in the field of neuroscience research, and biomarker discovery in psychiatry. The meeting is intended for researchers interested in stem cells, brain development, neuroimmunology and neuropsychiatry and will serve as a forum for scientific exchange and networking within the vibrant Lemanic Area research community. A prize will be awarded to the best poster presentation.

Keynote Speakers

Abstract Submission

  • Deadline for abstract submission: May 17, 2024

If you are interested in presenting a poster or  being selected for a short talk, please submit your abstract during the registration process.

  • Abstract preparation and format

Please submit a title of no more than 20 words, and keep your abstract to no more than 200 words. In addition, please also submit affiliations of all authors in the following format:

Adams, A.(1), Smith, S.(1,2), & Jones, J.(2),
1 Center for Brain Science, Harvard University, USA
2 Brain Mind Institute, EPFL, Switzerland
Corresponding author: a.adams@harvard.edu

  • If your contribution has been accepted

You will be notified 2 weeks prior. Your poster would have to meet the following requirements: size A0 : 119 × 84 cm (height x width), vertical. Your poster should not be sent out before the symposium. Simply bring it along on the day of the symposium, where it can be put up before the welcome address.

PhD Credits

LNDS and EDNE doctoral students have the opportunity to attend this symposium with an exam to receive 1 ECTS. The course is proposed under the umbrella of the LNDS: https://wp.unil.ch/lemanicneuroscience/lnds-phd-courses/. To take the course, please indicate "course option" during the registration process.


Prof. Pierre J. Magistretti, Dr. Théo Ribierre, Dr. Gabriele Grenningloh


Fondation NeuroNA, Vizgen, Bucher Biotech AG, STEMCELL